Analysis of transcription factors determining azole resistance of Aspergillus fumigatus

烟曲霉唑类抗性转录因子分析

基本信息

  • 批准号:
    10451817
  • 负责人:
  • 金额:
    $ 50.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-06 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

Invasive Aspergillosis caused by azole resistant A. fumigatus has a mortality rate nearing an alarming 90%, making this a clinical problem of acute significance. Early work on A. fumigatus suggested that azole resistance was rare and that the genetic basis of resistance was most often due to changes in a gene (cyp51A) encoding the azole target protein, lanosterol α-14 demethylase. Recent work from our groups has provided evidence that expression of an ATP-binding cassette (ABC) transporter-encoding gene called abcG1 (aka cdr1B) is linked to azole resistance in the absence of any changes at the cyp51A locus. Here we propose to investigate a key transcriptional regulator called AtrR that coordinately regulates expression of both cyp51A and abcG1. AtrR is a Zn2Cys6 zinc cluster-containing factor that resembles other fungal transcriptional regulators of drug resistance. We have found that loss of the atrR gene eliminated the high-level azole resistance seen in clinical isolates. Additional, preliminary data generated by use of chromatin immunoprecipitation coupled with high throughput DNA sequencing (ChIP-seq) and RNA-seq have shed light on direct and indirect targets of AtrR regulation. We have generated two different hyperactive alleles of atrR that drive elevated expression of abcG1 and enhanced azole resistance. These data suggest that AtrR is normally subject to negative regulation that can be overcome in different manners. We suggest that defects in this negative regulatory system may influence clinically significant azole resistance owing to increased expression of AtrR-dependent target genes (like abcG1 and cyp51A). The goal of this proposal is to employ a combined biochemical, molecular biological and genetic dissection of the regulation of AtrR in order to understand how this factor acts to induce azole resistance. Our initial goal is to carry out a structure/function analysis of AtrR and identify protein domains that are important for regulation of this factor. We will also use direct biochemical purification to identify factors that associate with AtrR and influence its function. Second, we will use forward genetic screening involving impala transposon mutagenesis to identify AtrR regulatory factors in an unbiased, functional manner. Finally, we will examine the role of an AtrR target gene that encodes a transcription factor called RfeC. Preliminary data indicate that RfeC is important in AbcG1 expression and azole resistance. We will examine the epistatic relationship between our atrR alleles and rfeC (as well as other azole resistance-affecting transcription factors) to establish the regulatory hierarchy controlling azole resistance. These experiments will illuminate the physiological network controlling AtrR that directly links ergosterol biosynthesis to ABC transporter gene expression and provide important new information about azole resistance in this fungal pathogen.
由抗唑烟曲霉引起的侵袭性曲霉病的死亡率接近惊人的90%,使其成为一个具有急性意义的临床问题。早期对烟曲霉的研究表明,对唑的抗性是罕见的,抗性的遗传基础通常是由于编码唑靶蛋白羊毛甾醇α-14去甲基化酶的基因cyp51A的改变。我们小组最近的工作提供了证据,证明在cyp51A位点没有任何变化的情况下,atp结合盒(ABC)转运蛋白编码基因abcG1(又名cdr1B)的表达与唑抗性有关。在这里,我们建议研究一种称为AtrR的关键转录调节因子,它协调调节cyp51A和abcG1的表达。AtrR是一种含有Zn2Cys6锌簇的因子,类似于其他真菌耐药转录调节因子。我们发现atrR基因的缺失消除了临床分离株的高水平唑耐药性。此外,利用染色质免疫沉淀结合高通量DNA测序(ChIP-seq)和RNA-seq产生的初步数据揭示了AtrR调控的直接和间接靶点。我们已经产生了atrR的两个不同的高活性等位基因,它们驱动abcG1的表达升高并增强了对唑的抗性。这些数据表明,AtrR通常受到负面调节,可以通过不同的方式加以克服。我们认为,由于atrr依赖性靶基因(如abcG1和cyp51A)的表达增加,这种负调控系统的缺陷可能影响临床显著的唑耐药性。本提案的目标是采用生物化学、分子生物学和遗传学相结合的方法对AtrR的调控进行解剖,以了解该因子如何诱导唑抗性。我们的最初目标是进行AtrR的结构/功能分析,并确定对该因子调控重要的蛋白质结构域。我们还将使用直接生化纯化来确定与AtrR相关并影响其功能的因素。其次,我们将使用包括黑斑羚转座子突变在内的正向遗传筛查,以一种公正的、功能性的方式识别AtrR调节因子。最后,我们将研究AtrR靶基因的作用,该基因编码一种称为RfeC的转录因子。初步数据表明,RfeC在AbcG1表达和唑耐药性中起重要作用。我们将研究atrR等位基因和rfeC(以及其他影响唑抗性的转录因子)之间的上位性关系,以建立控制唑抗性的调控体系。这些实验将阐明控制AtrR的生理网络,将麦角甾醇的生物合成与ABC转运体基因表达直接联系起来,并为该真菌病原体的抗唑性提供重要的新信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

W Scott Moye-Rowley其他文献

W Scott Moye-Rowley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('W Scott Moye-Rowley', 18)}}的其他基金

Chemical genetic analysis of Candida glabrata CDR1 expression
光滑念珠菌CDR1表达的化学遗传分析
  • 批准号:
    10588383
  • 财政年份:
    2022
  • 资助金额:
    $ 50.82万
  • 项目类别:
Identification of virulence determinants under the transcriptional control of AtrR in Aspergillus fumigatus
烟曲霉 AtrR 转录控制下毒力决定簇的鉴定
  • 批准号:
    10088398
  • 财政年份:
    2020
  • 资助金额:
    $ 50.82万
  • 项目类别:
Identification of virulence determinants under the transcriptional control of AtrR in Aspergillus fumigatus
烟曲霉 AtrR 转录控制下毒力决定簇的鉴定
  • 批准号:
    9914775
  • 财政年份:
    2020
  • 资助金额:
    $ 50.82万
  • 项目类别:
Analysis of transcription factors determining azole resistance of Aspergillus fumigatus
烟曲霉唑类抗性转录因子分析
  • 批准号:
    10207376
  • 财政年份:
    2019
  • 资助金额:
    $ 50.82万
  • 项目类别:
Analysis of transcription factors determining azole resistance of Aspergillus fumigatus
烟曲霉唑类抗性转录因子分析
  • 批准号:
    10664888
  • 财政年份:
    2019
  • 资助金额:
    $ 50.82万
  • 项目类别:
A new pathway for azole resistance in Aspergillus fumigatus
烟曲霉唑类抗性的新途径
  • 批准号:
    8972533
  • 财政年份:
    2015
  • 资助金额:
    $ 50.82万
  • 项目类别:
A new pathway for azole resistance in Aspergillus fumigatus
烟曲霉唑类抗性的新途径
  • 批准号:
    9089985
  • 财政年份:
    2015
  • 资助金额:
    $ 50.82万
  • 项目类别:
Role of transcriptional regulation in Aspergillus fumigatus drug resistance
转录调控在烟曲霉耐药性中的作用
  • 批准号:
    8191041
  • 财政年份:
    2011
  • 资助金额:
    $ 50.82万
  • 项目类别:
Role of transcriptional regulation in Aspergillus fumigatus drug resistance
转录调控在烟曲霉耐药性中的作用
  • 批准号:
    8264953
  • 财政年份:
    2011
  • 资助金额:
    $ 50.82万
  • 项目类别:
Regulation of eukaryotic membrane structure and function
真核细胞膜结构和功能的调节
  • 批准号:
    8033388
  • 财政年份:
    2010
  • 资助金额:
    $ 50.82万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 50.82万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了